We recently described two novel arylbindingsites of farnesyltransferase. The 4‐ and 5‐arylsubstituted thienylacryloyl moieties turned out as appropriate substituents for our benzophenone‐based AAX—peptidomimetic capable for occupying the fararylbindingsite.